학술논문

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Document Type
Article
Author
Vranckx, P.Benit, E.Valgimigli, M.Moschovitis, A.Windecker, S.Jüni, P.Hamm, C.Möllmann, H.Steg, P.G.Heg, D.van Es, G.A.McFadden, E.P.Onuma, Y.Van Geuns, R.J.Serruys, P.W.van Meijeren, C.Chichareon, P.Janssens, L.Ferrario, M.Zurakowski, A.Dominici, M.Huber, K.Slagboom, T.Abdellaoui, M.Adlam, D.Akin, I.Albarran Gonzalez-Trevilla, A.Almeida, M.Alves Lemos Neto, P.Aminian, A.Anderson, R.Andreae, R.Angioi, M.Asano, T.Barbato, E.Barlis, P.Barraud, P.Benit, E.Bertrand, O.Beygui, F.Bolognese, L.Botelho, R.Bouwman, C.Bressers, M.Brunel, P.Buszman, P.Buysschaert, I.Canas da Silva, P.Carrie, D.Cequier, A.Chichareon, P.Chin Chang, C.Chowdhary, S.Collet, C.Colombo, A.Cotton, J.Cruz Ferreira, R.Curello, S.Curzen, N.de Bot, J.de Vreede, T.Delle Karth, G.Dijksma, L.Édes, I.Eeckhout, E.Eitel, I.Faluközy, J.Fath-Ordoubadi, F.Fontos, G.Francisco Diaz, J.Freitas Quintella, E.Frey, B.Friedrich, G.Galasko, G.Galuszka, G.Gama Ribeiro, V.Garg, S.Gargiulo, G.Geisler, T.Gelev, V.Ghandilyan, A.Goicolea, J.Gori, T.Gragnano, F.Guimarães, A.Haude, M.Heg, D.Heijke, P.Hernández Antolin, R.A.Hildick-Smith, D.Hillen, D.Hoekman, I.Hofma, S.Holmvang, L.Hoole, S.Horváth, I.Huber, K.Hugense, A.Ibrahim, K.Iñiguez, A.Isaaz, K.Jambrik, Z.Janssens, L.Jasionowicz, P.Jonk, J.Jung, W.Katagiri, Y.Kogame, N.Koh, T.H.Koning, R.Konteva, M.Kőszegi, Z.Krackhardt, F.Kreuger, Y.Kukreja, N.Ladan, B.Lantelme, P.Leandro, S.Leibundgut, G.Liebetrau, C.Lindeboom, W.Macaya Miguel, C.Mach, F.Magro, M.Maillard, L.Manavifar, N.Mauri, L.McFadden, E.Merkely, B.Miyazaki, Y.Młodziankowski, A.Moccetti, T.Modolo, R.Möllman, H.Morelle, J.-F.Moschovitis, A.Munndt Ottesen, M.Muurling, M.Naber, C.K.Neumann, F.-J.Oldroyd, K.Ong, P.Palsrok, S.Petrov, I.Plante, S.Prokopczuk, J.Rademaker-Havinga, T.Raffel, C.Rensing, B.Roffi, M.Royaards, K.-J.Sabate, M.Schächinger, V.Seidler, T.Serra Peñaranda, A.Sikarulidze, L.Slagboom, T.Soliman, O.I.Sousa, A.Spitzer, E.Stables, R.Steg, G.Steinwender, C.Subkovas, E.Suryapranata, H.Takahashi, K.Talwar, S.Teiger, E.ter Weele, A.Teurlings, E.Thury, A.Tijssen, J.Tonev, G.Trendafilova-Lazarova, D.Tumscitz, C.Umans, V.Ungi, I.Valkov, V.van der Harst, P.van Geuns, R.J.van Meijeren, C.Vassilev, D.Velchev, V.Velthuizen, E.Verheugt, F.Vlcek, N.vom Dahl, J.Vrolix, M.Walsh, S.Werner, N.Windecker, S.Witsenburg, M.Zaman, A.Żmudka, K.Zrenner, B.Zurakowski, A.Zweiker, R.
Source
In: The Lancet. (The Lancet, 15 - 21 September 2018, 392(10151):940-949)
Subject
Language
English
ISSN
1474547X
01406736